Ireland

Sacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy

Recruiting

1 1 1 1
Investigated drugs:
+9
A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Recruiting

1 1 1
Investigated drugs:
+9
Study of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
- Cemiplimab
+1
Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
+9
Study of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer

Recruiting

1 1 1
Investigated diseases:
- Prostate cancer metastatic
Investigated drugs:
+1
A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Recruiting

1 1 1
Investigated drugs:
- Depemokimab
- Salbutamol Sulfate
+8

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

ABO haemolytic disease of newborn Acquired ATTR amyloidosis Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Addison's disease Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alpha-1 antitrypsin deficiency Alveolar proteinosis Amyotrophic lateral sclerosis Anaemia Anaemia of pregnancy Anti-glomerular basement membrane disease Antiphospholipid antibodies Arteriosclerosis Asthma Autonomic nervous system imbalance B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory Biliary neoplasm Bladder cancer Bladder cancer stage II Bladder cancer stage III Bladder transitional cell carcinoma Breast cancer Breast cancer female Breast cancer male Breast cancer metastatic Breast cancer recurrent Breast cancer stage I Breast cancer stage II Breast cancer stage III Bronchiectasis Bronchopulmonary dysplasia Cachexia Carcinoid syndrome Cardiac amyloidosis Cardiac failure Cardiomyopathy Cardiovascular disorder CDKL5 deficiency disorder Central nervous system neoplasm Cerebrovascular accident Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Chondrosarcoma Choroid melanoma Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic obstructive pulmonary disease Clear cell renal cell carcinoma Clostridium difficile infection Coeliac disease Colitis ulcerative Colon cancer Colorectal cancer Colorectal cancer metastatic Coronary artery disease COVID-19 Critical illness Crohn's disease Cystic fibrosis Cystic fibrosis respiratory infection suppression Decreased appetite Dementia Alzheimer's type Dermatitis atopic Diffuse large B-cell lymphoma Drug dependence Dry age-related macular degeneration Duchenne muscular dystrophy Elderly Embolic stroke Embolism venous Emphysema Endometrial adenocarcinoma Endometrial cancer Endometrial cancer recurrent Ependymoma Epidermolysis bullosa Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Food allergy Fragile X syndrome Friedreich's ataxia Gastric cancer Gastrointestinal cancer metastatic Gastrooesophageal cancer Generalised tonic-clonic seizure Glioblastoma Glomerulonephritis membranous Haematological malignancy Haemolytic uraemic syndrome Haemophilia Haemophilia A with anti factor VIII Hepatoblastoma Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis HIV infection Hodgkin's disease Homocystinuria Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Hypergammaglobulinaemia benign monoclonal Hypertension Hypertrophic cardiomyopathy Hypoxic-ischaemic encephalopathy Idiopathic inflammatory myopathy Idiopathic pulmonary fibrosis Immune thrombocytopenia Indolent systemic mastocytosis Iron deficiency anaemia Juvenile idiopathic arthritis K-ras gene mutation Left ventricular dysfunction Lung disorder Lung neoplasm malignant Lymphatic malformation Major depression Malignant glioma Malignant melanoma Malignant neoplasm of choroid Malignant peritoneal neoplasm Mantle cell lymphoma Marginal zone lymphoma Mechanical ventilation Metabolic dysfunction-associated steatohepatitis Metastatic renal cell carcinoma Monkeypox Monkeypox immunisation Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Myopia Myotonic dystrophy Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV NTRK gene fusion overexpression Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Open angle glaucoma Oropharyngeal cancer Osteochondrodysplasia Osteogenesis imperfecta Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian epithelial cancer Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma Pancreatic carcinoma metastatic Paroxysmal nocturnal haemoglobinuria Partial seizures Patent ductus arteriosus PD-L1 positive cancer Phenylketonuria PIK3CA related overgrowth spectrum PIK3CA-activated mutation Plasma cell myeloma Plasma cell myeloma refractory Pneumonia Polycythaemia vera Polyneuropathy Porphyria non-acute Post-traumatic stress disorder Postoperative wound infection Premature baby Primary amyloidosis Primary myelofibrosis Procedural pain Prostate cancer Prostate cancer metastatic Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary fibrosis Rectal cancer Relapsing multiple sclerosis Renal cancer metastatic Renal cell carcinoma Renal cell carcinoma stage IV Respiratory tract infection Retinal artery occlusion Rhabdomyosarcoma Richter's syndrome Secondary progressive multiple sclerosis Serous cystadenocarcinoma ovary Sickle cell disease Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer recurrent Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Systemic lupus erythematosus Systemic mastocytosis Systemic scleroderma Testicular germ cell cancer Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Transitional cell carcinoma urethra Triple negative breast cancer Type 2 diabetes mellitus Uveal melanoma Vascular malformation Von Willebrand's disease Waldenstrom's macroglobulinaemia

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes